Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-14 | CHRISTIAN S. SCHADE has been a director of the Company since 2006. Mr. Schade is 53 years old. |
| 2015-04-15 | CHRISTIAN S. SCHADE has been a director of the Company since 2006. He serves on the Audit Committee and Finance Committee (chair). Director compensation table shows $215,532 total compensation. |
| 2016-04-15 | CHRISTIAN S. SCHADE has been a director since 2006. He serves on the Audit and Finance Committees. Director compensation table shows total compensation of $314,009. |
| 2016-11-07 | Principal Stockholders table lists Christian S. Schade as a director with beneficial ownership details. |
| 2017-04-17 | CHRISTIAN S. SCHADE has been a director of the Company since 2006. The members of the Audit Committee are Mr. Murphy (chair), Mr. Howell, Mr. Schade and Mr. Sullivan. The members of the Finance Committee are Mr. Schade (chair), Mr. Howell and Mr. Murphy. Christian S. Schade compensation: $260,027. |
| 2018-04-06 | Christian S. Schade has been a director of the Company since 2006. The members of the Audit Committee are Mr. Murphy (chair), Mr. Schade and Mr. Sullivan. The members of the Finance Committee are Mr. Schade (chair), Mr. Howell and Mr. Murphy. The following table provides details of the total compensation for non-employee directors in 2017. Christian S. Schade received $260,006. |
| 2019-04-16 | Christian S. Schade has been a director of the Company since 2006. He currently serves as the President and Chief Executive Officer of Aprea Therapeutics AB. Mr. Schade is the Chair of the Finance Committee. Mr. Schade is 58 years old. |
| 2020-04-08 | CHRISTIAN S. SCHADE has been a director of the Company since 2006. Mr. Schade is 59 years old. |
| 2021-04-09 | CHRISTIAN S. SCHADE has been a director of the Company since 2006. Mr. Schade is 60 years old. He serves on the Audit and Finance Committees. |
| 2022-04-08 | CHRISTIAN S. SCHADE has been a director of the Company since 2006. Mr. Schade is 61 years old. The members of the Finance Committee are Mr. Schade (chair), Dr. Bradley and Mr. Murphy. The members of the Audit Committee are Mr. Murphy (chair), Ms. Clay, and Mr. Schade. |
| 2023-04-06 | Mr. Schade currently serves as a Growth Partner at Flagship Pioneering. Committees: Audit (Chair), Finance (Chair). Total compensation: $313,800. |
| 2024-04-04 | Christian S. Schade – Growth Partner, Flagship Pioneering ... Age: 63 ... Director since: 2006 ... Committees: Audit (Chair), Finance (Chair) ... Fees Earned or Paid in Cash: 73,242 ... Stock Awards: 220,038 ... Total: 293,280 |
| 2025-04-04 | Christian S. Schade – Chief Executive Officer, Halda Therapeutics LLC. Age: 64 Director since: 2006 Committees: Audit (Chair), Finance (Chair). Compensation: Fees Earned or Paid in Cash $115,000, Stock Awards $220,009, Total $335,009. |
Data sourced from SEC filings. Last updated: 2026-02-03